[시장보고서]양막 제품 시장 : 세계 규모, 점유율, 동향 분석, 기회, 예측 리포트(2019-2030년)

양막 제품 시장 : 세계 규모, 점유율, 동향 분석, 기회, 예측 리포트(2019-2030년)

Amniotic Products Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Type ; By End User ; By Application ; By Region

상품코드 : 1410992

리서치사 : Blueweave Consulting

발행일 : 2024년 01월

페이지 정보 : 영문 400 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,850

￦ 7,002,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,750

￦ 8,301,000

Unprintable PDF (Group License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150

￦ 11,766,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. Excel 파일이 제공됩니다.

ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 양막 제품 시장 규모는 2030년까지 13억 달러를 돌파, 2024-2030년 CAGR은 8.56%로 확대

양막 제품의 이점에 대한 인식이 증가, 양막 제품 연구개발에 대한 투자가 증가하고 있는 것으로 인해 세계의 양막 제품 시장은 견인력을 확대하고 있습니다.

전략 컨설팅 및 시장 조사 대기업인 BlueWeave Consulting은 최근 조사에서 세계의 양막 제품 시장 규모를 2023년에 8억 1,040만 달러로 추정했습니다. 2024-2030년의 예측 기간 중 BlueWeave는 세계의 양막 제품 시장 규모가 CAGR 8.56%로 성장하며, 2030년에는 13억 2,620만 달러에 달할 것으로 예측하고 있습니다. 피부 및 눈 질환의 치료에서 양막 제품의 사용 증가 및 궤양 등 만성 창상의 발생률 증가가 세계 양막 제품 시장의 중요한 촉진요인입니다. 또한 분석 기간 중 양막 제품에 관한 연구개발 프로그램의 증가가 시장 성장을 촉진할 것으로 예상됩니다.

본 리포트의 상세 분석에 의해 성장 가능성, 향후 동향, 세계의 양막 제품 시장에 관한 정보를 제공합니다. 또한 전체 시장 규모의 예측을 촉진하는 요인도 분명히 하고 있습니다. 세계의 양막 제품 시장의 최근 기술 동향 및 업계 인사이트를 제공하고, 의사결정자가 건전한 전략적 의사결정을 시행할 수 있도록 지원할 것을 약속합니다. 또한 시장의 성장 촉진요인·과제·경쟁 역학에 대해서도 분석하고 있습니다.

업계의 밸류체인 분석
DROC 분석
- 성장 촉진요인
  - 만성 창상의 이환율 증가
  - 양막 제품의 이점에 대한 인식의 향상
  - 양막 제품 연구개발에 대한 투자를 확대
- 억제요인
  - 양막의 가용성은 한정되어 있다.
  - 대체 창상 치료 제품과의 경쟁
- 기회
  - 재생의료에 대한 응용 확대
  - 신흥 시장에서의 수요 확대
- 과제
  - 양막 제품의 품질과 일관성 유지
  - 양막 제품에 관한 헬스케어 전문가에 대한 교육
기술의 진보/최근 개발
소비자 행동과 인사이트
규제 프레임워크
Porter's Five Forces 분석

제4장 세계의 양막 제품 시장 개요

시장 규모와 예측, 2019-2030년
- 금액별
시장 점유율과 예측
- 유형별
  - 동결보존 양막
  - 탈수 양막
- 최종사용자별
  - 병원 및 외래 수술 센터
  - 기타
- 용도별
  - 창상관리
  - 정형외과
  - 안과
  - 기타
- 지역별
  - 북미
  - 유럽
  - 아시아태평양(APAC)
  - 라틴아메리카(LATAM)
  - 중동 및 아프리카(MEA)

제5장 북미의 양막 제품 시장

시장 규모와 예측, 2019-2030년
- 금액별
시장 점유율과 예측
- 유형별
- 최종사용자별
- 용도별
- 국가별
  - 미국
  - 캐나다

제6장 유럽의 양막 제품 시장

시장 규모와 예측, 2019-2030년
- 금액별
시장 점유율과 예측
- 유형별
- 최종사용자별
- 용도별
- 국가별
  - 독일
  - 영국
  - 이탈리아
  - 프랑스
  - 스페인
  - 벨기에
  - 러시아
  - 네덜란드
  - 기타

제7장 아시아태평양의 양막 제품 시장

시장 규모와 예측, 2019-2030년
- 금액별
시장 점유율과 예측
- 유형별
- 최종사용자별
- 용도별
- 국가별
  - 중국
  - 인도
  - 일본
  - 한국
  - 호주와 뉴질랜드
  - 인도네시아
  - 말레이시아
  - 싱가포르
  - 베트남
  - 기타

제8장 라틴아메리카의 양막 제품 시장

시장 규모와 예측, 2019-2030년
- 금액별
시장 점유율과 예측
- 유형별
- 최종사용자별
- 용도별
- 국가별
  - 브라질
  - 멕시코
  - 아르헨티나
  - 페루
  - 기타

제9장 중동 및 아프리카의 양막 제품 시장

시장 규모와 예측, 2019-2030년
- 금액별
시장 점유율과 예측
- 유형별
- 최종사용자별
- 용도별
- 국가별
  - 사우디아라비아
  - 아랍에미리트
  - 카타르
  - 쿠웨이트
  - 남아프리카공화국
  - 나이지리아
  - 알제리
  - 기타

제10장 경쟁 구도

주요 기업과 제품 리스트
세계의 양막 제품 시장 점유율 분석, 2023년
경영 파라미터에 의한 경쟁 벤치마킹
주요 전략적 개발(합병, 인수, 파트너십 등)

제11장 지정학적 긴장이 세계의 양막 제품 시장에 미치는 영향

제12장 기업 개요(회사 개요, 재무 매트릭스, 경쟁 구도, 주요 인재, 주요 경쟁, 연락처 주소, 전략적 전망, SWOT 분석)

MiMedx Group
Organogenesis
Smith &Nephew
Integra LifeSciences
Amniox Medical
AmnioTech
Skye Biologics
Applied Biologics
TissueTech
Katena Products
기타 주요 기업

제13장 주요 전략적 권장사항

제14장 조사 방법

KSA

영문 목차

영문목차

Global Amniotic Products Market Size Set to Surpass USD 1.3 Billion by 2030, Expanding at CAGR of 8.56% During 2024-2030.

Global Amniotic Products Market is gaining traction because of the growing awareness about the benefits of amniotic products and increasing investments in amniotic product research and development.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Amniotic Products Market size at USD 810.4 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Amniotic Products Market size to grow at a CAGR of 8.56% reaching a value of USD 1,326.2 million by 2030. The increasing use of amniotic products in the treatment of skin and eye conditions, as well as the growing incidence of chronic wounds, such as ulcers, are significant driving factors for the Global Amniotic Products Market. Moreover, over the period in analysis, it is expected that growing number of research and development programs on amniotic products will propel market growth.

Opportunity: Increasing number of amniotic product launches

The rising adoption of amniotic products in the healthcare sector owing to their therapeutic properties is also influencing product launches and research and development programs in the field. For instance, Amnio Technology, a United States-based developer and manufacturer of amnion-derived technologies, announced the launch of two new PalinGen membrane products, PalinGen Dual-Layer Membrane, and Dual Layer PalinGen X-Membrane. Versea Health, Inc., another US-based pharmaceutical products company, is launching Biovance 3L ocular tri-layer human amniotic membrane.

Global Amniotic Products Market - By End User

Based on end user, the Global Amniotic Products Market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment holds the largest share of the Global Amniotic Products Market by end user. The growth of the segment is mainly attributed to the high number of outpatient visits for wound treatment and surgical procedures. Amniotic membranes are mostly obtained at hospitals for use in tendon and ligament repair or for ophthalmic purposes. Hospital billing and reimbursement for these products are also easily obtained, which is a key factor contributing to the growth of the hospitals segment.

Impact of Escalating Geopolitical Tensions on Global Amniotic Products Market

The escalating geopolitical tensions are negatively impacting the growth of the Global Amniotic Products Market. Ukraine has a flourishing medical tourism sector. The country offers cost-effective quality healthcare. Ukraine's medical sector was increasingly becoming the hub for specialized treatments not readily available in other countries. However, with Russia's war on Ukraine, medical tourism dwindled, and the number of surgeries performed in the country declined at a staggering rate owing to the sensitive situation in the country and a lack of resources. It resulted in a significant decline in the demand for amniotic products for healthcare purposes as well as hindered research and development activities, limiting its market growth.

Global Amniotic Products Market - By Region

The in-depth research report on the Global Amniotic Products Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Amniotic Products Market. The rising healthcare expenditure, coupled with the increasing prevalence of chronic wounds and diabetes, as well as the high concentration of amniotic product manufacturers, are directly influencing market growth. However, the Asia Pacific region is projected to register a high growth rate during the forecast period owing to the growing geriatric population in East Asian countries, including Japan and South Korea.

Competitive Landscape

Major players operating in the Global Amniotic Products Market include: MiMedx Group, Organogenesis, Smith & Nephew, Integra LifeSciences, Amniox Medical, AmnioTech, Skye Biologics, Applied Biologics, TissueTech, and Katena Products. These companies employ various strategies to further enhance their market share, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don't miss the business opportunity in the Global Amniotic Products Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Amniotic Products Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Amniotic Products Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Amniotic Products Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Increasing Prevalence of Chronic Wounds
  - 3.2.1.2. Growing Awareness of the Benefits of Amniotic Products
  - 3.2.1.3. Increasing Investments in Amniotic Product Research and Development
- 3.2.2. Restraints
  - 3.2.2.1. Limited Availability of Amniotic Membranes
  - 3.2.2.2. Competition from Alternative Wound Care Products
- 3.2.3. Opportunities
  - 3.2.3.1. Expanding Applications in Regenerative Medicine
  - 3.2.3.2. Growing Demand in Emerging Markets
- 3.2.4. Challenges
  - 3.2.4.1. Maintaining the Quality and Consistency of Amniotic Products
  - 3.2.4.2. Educating Healthcare Professionals about Amniotic Products
3.3. Technological Advancements/Recent Developments
3.4. Consumer Behavior and Insights
3.5. Regulatory Framework
3.6. Porter's Five Forces Analysis
- 3.6.1. Bargaining Power of Suppliers
- 3.6.2. Bargaining Power of Buyers
- 3.6.3. Threat of New Entrants
- 3.6.4. Threat of Substitutes
- 3.6.5. Intensity of Rivalry

4. Global Amniotic Products Market Overview

4.1. Market Size & Forecast, 2019-2030
- 4.1.1. By Value (USD Million)
4.2. Market Share and Forecast
- 4.2.1. By Type
  - 4.2.1.1. Cryopreserved Amniotic Membrane
  - 4.2.1.2. Dehydrated Amniotic Membrane
- 4.2.2. By End User
  - 4.2.2.1. Hospitals & Ambulatory Surgical Centers
  - 4.2.2.2. Others
- 4.2.3. By Application
  - 4.2.3.1. Wound Care
  - 4.2.3.2. Orthopedics
  - 4.2.3.3. Ophthalmology
  - 4.2.3.4. Others
- 4.2.4. By Region
  - 4.2.4.1. North America
  - 4.2.4.2. Europe
  - 4.2.4.3. Asia Pacific (APAC)
  - 4.2.4.4. Latin America (LATAM)
  - 4.2.4.5. Middle East and Africa (MEA)

5. North America Amniotic Products Market

5.1. Market Size & Forecast, 2019-2030
- 5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
- 5.2.1. By Type
- 5.2.2. By End User
- 5.2.3. By Application
- 5.2.4. By Country
  - 5.2.4.1. United States
  - 5.2.4.1.1. By Type
  - 5.2.4.1.2. By End User
  - 5.2.4.1.3. By Application
  - 5.2.4.2. Canada
  - 5.2.4.2.1. By Type
  - 5.2.4.2.2. By End User
  - 5.2.4.2.3. By Application

6. Europe Amniotic Products Market

6.1. Market Size & Forecast, 2019-2030
- 6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By End User
- 6.2.3. By Application
- 6.2.4. By Country
  - 6.2.4.1. Germany
  - 6.2.4.1.1. By Type
  - 6.2.4.1.2. By End User
  - 6.2.4.1.3. By Application
  - 6.2.4.2. United Kingdom
  - 6.2.4.2.1. By Type
  - 6.2.4.2.2. By End User
  - 6.2.4.2.3. By Application
  - 6.2.4.3. Italy
  - 6.2.4.3.1. By Type
  - 6.2.4.3.2. By End User
  - 6.2.4.3.3. By Application
  - 6.2.4.4. France
  - 6.2.4.4.1. By Type
  - 6.2.4.4.2. By End User
  - 6.2.4.4.3. By Application
  - 6.2.4.5. Spain
  - 6.2.4.5.1. By Type
  - 6.2.4.5.2. By End User
  - 6.2.4.5.3. By Application
  - 6.2.4.6. Belgium
  - 6.2.4.6.1. By Type
  - 6.2.4.6.2. By End User
  - 6.2.4.6.3. By Application
  - 6.2.4.7. Russia
  - 6.2.4.7.1. By Type
  - 6.2.4.7.2. By End User
  - 6.2.4.7.3. By Application
  - 6.2.4.8. The Netherlands
  - 6.2.4.8.1. By Type
  - 6.2.4.8.2. By End User
  - 6.2.4.8.3. By Application
  - 6.2.4.9. Rest of Europe
  - 6.2.4.9.1. By Type
  - 6.2.4.9.2. By End User
  - 6.2.4.9.3. By Application

7. Asia Pacific Amniotic Products Market

7.1. Market Size & Forecast, 2019-2030
- 7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By End User
- 7.2.3. By Application
- 7.2.4. By Country
  - 7.2.4.1. China
  - 7.2.4.1.1. By Type
  - 7.2.4.1.2. By End User
  - 7.2.4.1.3. By Application
  - 7.2.4.2. India
  - 7.2.4.2.1. By Type
  - 7.2.4.2.2. By End User
  - 7.2.4.2.3. By Application
  - 7.2.4.3. Japan
  - 7.2.4.3.1. By Type
  - 7.2.4.3.2. By End User
  - 7.2.4.3.3. By Application
  - 7.2.4.4. South Korea
  - 7.2.4.4.1. By Type
  - 7.2.4.4.2. By End User
  - 7.2.4.4.3. By Application
  - 7.2.4.5. Australia & New Zealand
  - 7.2.4.5.1. By Type
  - 7.2.4.5.2. By End User
  - 7.2.4.5.3. By Application
  - 7.2.4.6. Indonesia
  - 7.2.4.6.1. By Type
  - 7.2.4.6.2. By End User
  - 7.2.4.6.3. By Application
  - 7.2.4.7. Malaysia
  - 7.2.4.7.1. By Type
  - 7.2.4.7.2. By End User
  - 7.2.4.7.3. By Application
  - 7.2.4.8. Singapore
  - 7.2.4.8.1. By Type
  - 7.2.4.8.2. By End User
  - 7.2.4.8.3. By Application
  - 7.2.4.9. Vietnam
  - 7.2.4.9.1. By Type
  - 7.2.4.9.2. By End User
  - 7.2.4.9.3. By Application
  - 7.2.4.10. Rest of APAC
  - 7.2.4.10.1. By Type
  - 7.2.4.10.2. By End User
  - 7.2.4.10.3. By Application

8. Latin America Amniotic Products Market

8.1. Market Size & Forecast, 2019-2030
- 8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By End User
- 8.2.3. By Application
- 8.2.4. By Country
  - 8.2.4.1. Brazil
  - 8.2.4.1.1. By Type
  - 8.2.4.1.2. By End User
  - 8.2.4.1.3. By Application
  - 8.2.4.2. Mexico
  - 8.2.4.2.1. By Type
  - 8.2.4.2.2. By End User
  - 8.2.4.2.3. By Application
  - 8.2.4.3. Argentina
  - 8.2.4.3.1. By Type
  - 8.2.4.3.2. By End User
  - 8.2.4.3.3. By Application
  - 8.2.4.4. Peru
  - 8.2.4.4.1. By Type
  - 8.2.4.4.2. By End User
  - 8.2.4.4.3. By Application
  - 8.2.4.5. Rest of LATAM
  - 8.2.4.5.1. By Type
  - 8.2.4.5.2. By End User
  - 8.2.4.5.3. By Application

9. Middle East & Africa Amniotic Products Market

9.1. Market Size & Forecast, 2019-2030
- 9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By End User
- 9.2.3. By Application
- 9.2.4. By Country
  - 9.2.4.1. Saudi Arabia
  - 9.2.4.1.1. By Type
  - 9.2.4.1.2. By End User
  - 9.2.4.1.3. By Application
  - 9.2.4.2. UAE
  - 9.2.4.2.1. By Type
  - 9.2.4.2.2. By End User
  - 9.2.4.2.3. By Application
  - 9.2.4.3. Qatar
  - 9.2.4.3.1. By Type
  - 9.2.4.3.2. By End User
  - 9.2.4.3.3. By Application
  - 9.2.4.4. Kuwait
  - 9.2.4.4.1. By Type
  - 9.2.4.4.2. By End User
  - 9.2.4.4.3. By Application
  - 9.2.4.5. South Africa
  - 9.2.4.5.1. By Type
  - 9.2.4.5.2. By End User
  - 9.2.4.5.3. By Application
  - 9.2.4.6. Nigeria
  - 9.2.4.6.1. By Type
  - 9.2.4.6.2. By End User
  - 9.2.4.6.3. By Application
  - 9.2.4.7. Algeria
  - 9.2.4.7.1. By Type
  - 9.2.4.7.2. By End User
  - 9.2.4.7.3. By Application
  - 9.2.4.8. Rest of MEA
  - 9.2.4.8.1. By Type
  - 9.2.4.8.2. By End User
  - 9.2.4.8.3. By Application

10. Competitive Landscape

10.1. List of Key Players and Their Offerings
10.2. Global Amniotic Products Market Share Analysis, 2023
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Geopolitical Tension on Global Amniotic Products Market

12. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

12.1. MiMedx Group
12.2. Organogenesis
12.3. Smith & Nephew
12.4. Integra LifeSciences
12.5. Amniox Medical
12.6. AmnioTech
12.7. Skye Biologics
12.8. Applied Biologics
12.9. TissueTech
12.10. Katena Products
12.11. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

14.1. Qualitative Research
- 14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
- 14.3.1. Secondary Research
- 14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations